USA
Intellectual Property
Pharmaceutical
April 2012
Vol. 5, No. 19, Spring 2012
Sharon Reiche
More
Sharon Reiche is Corporate Counsel, Intellectual Property Policy, at Pfizer Inc. In her role as Corporate Counsel she works on IP policies that advance the protection of Pfizer’s substantial investment in research and development. She holds a BS from the University of Massachusetts, Amherst, and a J.D. from Brooklyn Law School.
Sharon Reiche
More
Sharon Reiche is Corporate Counsel, Intellectual Property Policy, at Pfizer Inc. In her role as Corporate Counsel she works on IP policies that advance the protection of Pfizer’s substantial investment in research and development. She holds a BS from the University of Massachusetts, Amherst, and a J.D. from Brooklyn Law School.
Pfizer Inc
More
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.
USA
Intellectual Property
Pharmaceutical
April 2012
Vol. 5, No. 19, Spring 2012